RXi Pharmaceuticals
RXi Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics. The company has developed self-delivering RNAi compounds for the treatment of dermal and retinal scarring and is also working on a proprietary topical formulation of diphenylcyclopropenone for the treatment of warts, alopecia areata and cutaneous metastases of melanoma.
primaryTopic
RXi Pharmaceuticals
RXi Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. The company is using its siRNA platform to develop a pipeline of dermatology and ophthalmology therapeutics. The company has developed self-delivering RNAi compounds for the treatment of dermal and retinal scarring and is also working on a proprietary topical formulation of diphenylcyclopropenone for the treatment of warts, alopecia areata and cutaneous metastases of melanoma.
has abstract
RXi Pharmaceuticals Inc. is a ...... aneous metastases of melanoma.
@en
founding year
industry
key person
location
type
Link from a Wikipage to an external page
Wikipage page ID
35,289,132
Wikipage revision ID
732,386,488
subject
comment
RXi Pharmaceuticals Inc. is a ...... aneous metastases of melanoma.
@en
label
RXi Pharmaceuticals
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
RXi Pharmaceuticals
@en